NeoGenomics provides cancer diagnostic testing and pathology interpretation services for doctors, hospitals and drug developers. Analyst consensus is Strong Buy, based on the latest ratings from 4 firms (4 buy, 0 hold, 0 sell). In the past 30 days there were 2 dark pool prints.
Analyst Ratings & Price Targets
Analyst Ratings →| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Oct 29 | TD Cowen | Maintained | Buy | |
| Oct 29 | BTIG | Reiterated | Buy | |
| Oct 6 | StoneX | Maintained | Buy | |
| Oct 6 | Needham | Target raised | Buy | |
| Oct 6 | BTIG | Upgrade | Buy |
Whale Options Flow
90DNo whale options trades in NEO in the last 90 days.
Dark Pool
30DAI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether NEO is in one of them and how their past NEO trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered NEO in an article yet. Here's the latest on the wider market.
NEO Congress Trades
All congress trades →
| Person | Type | Amount | Traded | Filed | Delay |
|---|---|---|---|---|---|
| Gilbert CisnerosD · CA | Buy | $1K – $15K | Aug 7, 2026 | Sep 11, 2026 | 35 d |
| Donald J TrumpExecutive branch | Sell | $15K – $50K | May 15, 2026 | Jul 1, 2026 | 47 d |
| Donald J TrumpExecutive branch | Buy | $15K – $50K | Mar 4, 2026 | May 14, 2026 | 71 d |
| Gilbert CisnerosD · CA | Buy | $1K – $15K | May 7, 2025 | Jun 6, 2025 | 30 d |
| Deborah k. RossD · NC | Buy | $15K – $50K | Dec 30, 2021 | Jan 8, 2022 | 9 d |
Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.
About Neogenomics
NeoGenomics provides cancer diagnostic testing and related consulting services from its headquarters in Fort Myers, Florida. Its laboratories run tests such as cytogenetics, flow cytometry, molecular and sequencing panels, and residual disease testing, and its pathologists and molecular experts interpret the results. Its customers include community pathology and oncology practices, hospitals, reference labs, academic centers and pharmaceutical companies. The company also offers research support and data licensing services to drug developers.
- Headquarters
- Fort Myers, FL
- Founded
- 2002
- Website
- neogenomics.com ↗